Roche Canada Funding Request Tool

At Roche Canada, patients and science are at the heart of everything we do. Thus, we welcome opportunities to invest in initiatives and collaborate with organizations that drive healthcare forward. We are committed to delivering meaningful benefits to patients and a sustainable healthcare system.  

Funding Opportunities

Roche Canada offers funding support in the form of sponsorships, grants, and international conference support (ICS).

We prioritize funding requests that:

  1. Align with our focus areas and create opportunities in new areas, like artificial intelligence, innovation and real world evidence.
  2. Improve patient care and outcomes.
  3. Advance medical research and education.

Current Grant Opportunities

Roche will occasionally seek applications through a Call for Grants process. The Call for Grants provides public notice of the availability of funds to support initiatives that address a current unmet, validated educational need aligned to Roche’s scientific strategy.

Below you will find the current open grant opportunities:

Area of Therapeutic or Policy Interest

Accepting Intake Cycle 4 Grants 

(Aug 1 - Oct 31)

RFP or Areas of Focus

Cardiovascular, Renal & Metabolism

No

  

Health Systems Shaping

Yes

Public Policy Initiative on Medication Access in Rural and Remote Areas

Immunology

No

  

Neuroimmunology

Yes

Multiple Sclerosis:

  • Efforts supporting understanding of anti-CD20 therapies that address knowledge gaps in MS treatment  in an evolving landscape, and the role of biomarkers in decision-making.  

  • Requests related to enhancing healthcare infrastructure and processes to streamline MS care delivery, such as improving the infusion experience, optimizing shorter infusion protocols, and facilitating efficient early adoption of High Efficacy therapies 

  • Education efforts targeting HCPs patient treatment dialogues in MS.

Oncology

Yes

Lung: 

  • Efforts supporting decentralized oncology care that enhance or facilitate educational discussions with multi-disciplinary teams 

  • Efforts supporting feasibility of out-of-hospital administration of lung oncology management

Breast:

  • Requests related to biomarker testing that impact treatment decision making in breast cancer

  • Education efforts to improve safe use of breast oncology treatments and multi disciplinary care

  • Tools/methods supporting real-time rapid dissemination of new scientific data in breast

Hematology:

  • Educational requests related to biomarkers that impact treatment decision making in malignant hematology

  • Tools/methods supporting real-time rapid scientific dissemination of new scientific data in malignant heme

  • Requests related to improving the safe delivery of medicines in malignant heme to the multidisciplinary team

Gastrointestinal and Genitourinary (GI/GU):

  • Requests related to further understanding biomarker signatures to assist with clinical decision making in HCC

  • Tools/Methods supporting real-time, rapid scientific dissemination in HCC

  • Education efforts to improve liver multidisciplinary team collaboration

Ophthalmology

Yes

  • Support for medical retina and surgical retina  fellowships to cultivate specialized expertise within the Canadian ophthalmology community.

  • Development and implementation of innovative tools and methodologies to facilitate the real-time, rapid dissemination of new scientific data in ophthalmologic care with a focus on retinal vascular disease 

  • Educational requests related to the evolving landscape of treatment guidelines, further understanding of biomarkers, and the role of various cytokines in retinal vascular diseases. 

Other

Yes

  

Rare Disease (SMA, Hemophilia)

Yes

Spinal Muscular Atrophy (SMA)

  • Medical Education aimed at enhancing the understanding of clinical best practices for SMA management, including current care standards, diagnosis, multidisciplinary approaches, and ongoing care optimization.

  • Strategies for disseminating and translating new scientific data and clinical advancements

  • Initiatives addressing outcome assessments in SMA, including: motor function, fatigue and fatigability, bulbar dysfunction, cognition skills, patient reported outcomes and quality of life measures. 

  • Development of tools or initiatives (including events and camps) for HCPs, patients, and caregivers to enable better care experiences. Proposals may focus on fostering collaboration, improving care continuity, or addressing specific needs of patients and their families.

Hemophilia:

  • HCP, patient or community education tools, and/or resources in hemophilia A that support shared decision making and knowledge translation

  • Fellowship Support in bleeding disorders (non-malignant hematology)

  • Patient conferences / events / activities / camps that support disease education and management of hemophilia A

Roche continues to accept rolling grant requests through our Funding Request Tool.

Roche Canada also offers funding support in the form of philanthropic donations. We consider requests that explicitly align with our approach to philanthropy, which is rooted in a deep dedication to creating a better future for all.

We look to make a difference in these four areas:

  1. Humanitarian and Social Projects
  2. Science and Education Projects
  3. Culture and Arts Projects
  4. Community and Environment Projects

Applications for all four funding types are accepted throughout the year.

Eligibility

Roche can only consider funding requests submitted on behalf of and intended for eligible applicants and initiatives. 

For details on eligibility criteria, please review the Roche Canada Funding Resource.

Evaluation Process

Every funding request received will be evaluated separately for alignment with Roche’s funding policy (including the Innovative Medicines Canada (IMC) code). Previous support by Roche for a similar request does not guarantee future support; and depending on the nature of the request, only partial support may be provided.

For information on the evaluation process, please review our process maps.

Submission Tips

Unfortunately, Roche is unable to support all funding request submissions. For funding consideration, please ensure that your submission has met all the relevant requirements and detailed information about the proposed initiative is provided. 

As a reminder, only applications submitted through our online portal will be reviewed. 

We highly recommend that applications for funding support be submitted as early as possible. For international conference support, applications must be submitted at least 45 days in advance of the conference start date. For other funding requests or conferences, please submit your application at least 60 days in advance of the start date to allow our teams adequate time to thoroughly review your request. Please note that a written agreement must be in place before the initiative/conference start date.

Questions?

Review our FAQ for answers to commonly asked questions. You can also reach out to your Roche contact or submit an inquiry using this link.

 

Doing now what patients need next.

 

Submit a new application